Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5187420 | 0.91 | ERBB2 (0.55) | ERBB2MINK1 | |
| SCHEMBL5187416 | 0.91 | ERBB2 (0.55) | ERBB2MINK1 | |
| SCHEMBL5650406 | 0.88 | ERBB2 (0.51) | ERBB2MINK1 | |
| SCHEMBL27652953 | 0.88 | ERBB2 (0.51) | ERBB2MINK1 | |
| SCHEMBL5045350 | 0.87 | ERBB2 (0.51) | ERBB2MINK1 | |
| SCHEMBL5045353 | 0.87 | ERBB2 (0.51) | ERBB2MINK1 | |
| SCHEMBL5752858 | 0.87 | ERBB2 (0.72) | ERBB2MINK1 | |
| SCHEMBL5752855 | 0.87 | ERBB2 (0.72) | ERBB2MINK1 | |
| SCHEMBL24112037 | 0.86 | ERBB2 (0.71) | ERBB2MINK1 | |
| SCHEMBL5752039 | 0.86 | ERBB2 (0.71) | ERBB2MINK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20030069419-A1 | Method for producing 1-substituted-1,2,3- triazole derivative | TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030069419-A1 | Method for producing 1-substituted-1,2,3- triazole derivative | ABL1, YES1, MAP3K1 | ERBB2 77/4885MINK1 330/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.